CLONORGAN
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $7M
Investors
- 7
About CLONORGAN
Established in 2018 and based in Chengdu, China, CLONORGAN is a biological company that focuses on developing organ and tissue therapy techniques. The founder, Dengke Pan, is deputy Leader of the Xenotransplantation Group of the Organ Transplantation Society of the Chinese Medical Association. More than 22% of members of the research team have master's degrees. The company has been honored as a technology-based SME by the Ministry of Science and Technology, a Chinese-funded enterprise in Chengdu, and an Eagle Enterprise in Chengdu Hi-Tech Zone in 2019. The company provides biological products for xenogeneic organs and biomedical tissues, which adopt gene editing and cloning technology. It specializes in fund editing and cloning services, tissue organ transplantation trials such as liver, pancreatic islets, and kidneys, and clinical research. The product includes xenogeneic organ donor pigs, medical bio-donor pigs, and low immunogenicity biomaterials. The company generates revenue by providing gene editing and cloning services, experimental simulation of pigs, gene-edited human disease model pigs, etc.
Who invested in CLONORGAN
7 investors across 3 rounds
See all investors in CLONORGAN
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CLONORGAN
Who invested in CLONORGAN?
CLONORGAN has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CLONORGAN raised?
CLONORGAN has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CLONORGAN last raise money?
CLONORGAN's most recent round on record is a Series A, in Sep 2025.
What does CLONORGAN do?
Established in 2018 and based in Chengdu, China, CLONORGAN is a biological company that focuses on developing organ and tissue therapy techniques.
Where is CLONORGAN headquartered?
CLONORGAN is headquartered in Chengdu, China.
Which VCs invest in companies like CLONORGAN?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CLONORGAN's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CLONORGAN? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.